Stamped Prescription Now Mandatory for 11 Antibiotics in Egypt

The Egyptian Drug Authority (EDA) has announced new regulations aimed at curbing the misuse of certain antibiotics and ensuring their effectiveness in combating serious infections. These regulations, effective immediately, restrict the dispensing of 11 specific antibiotics classified as part of the Reserve group to those with a stamped prescription.

The move comes amidst growing concerns about antibiotic resistance, a global public health threat. The Reserve group antibiotics are typically used as a last line of defense against severe or resistant infections. Inappropriate use of these antibiotics can contribute to the development of antibiotic-resistant bacteria, rendering these life-saving medications ineffective.

The specific antibiotics affected by the new regulations include Azteonam, Ceftaroline-fosamil, Ceftaroline/avibactam, Ceftaroline/tazobactam, Colistin, Dalbavancin, Daptomycin, Linezolid, Tedizolid, and Tigecycline.

The EDA emphasizes that these regulations not only restrict access but also provide clear guidelines for the appropriate use, storage, and distribution of these Reserve group antibiotics. This comprehensive approach aims to ensure that these medications remain effective for treating severe infections while minimizing the risk of misuse.

The EDA has stressed the mandatory nature of these regulations for all entities involved in the dispensation and distribution of antibiotics in Egypt. Strict compliance will be monitored by the authority.